Electromed manufactures and sells the SmartVest Airway Clearance System, a medical device that uses High Frequency Chest Wall Oscillation therapy to help patients clear mucus from their airways. The SmartVest consists of an inflatable vest garment, an air pulse generator, and a connecting hose, enabling patients to self-administer daily therapy at home. Physicians prescribe the device primarily for bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Electromed operates primarily in the U.S. through a direct-to-patient homecare model. Its direct sales representatives market to pulmonologists and clinicians to generate prescriptions, and Electromed manages the complete fulfillment process internally, including insurance authorization, claim processing, patient in-home training via contracted respiratory therapists, and device delivery. The company collects reimbursement directly from third-party payers, including Medicare, Medicaid, and commercial insurers. Electromed also sells the SmartVest as capital equipment to hospitals and through home medical equipment distributors. Electromed's growth strategy centers on expanding its direct sales force, securing additional third-party payer contracts, and increasing physician awareness of bronchiectasis.